Pyocyanin reversibly inhibits Chlamydia by impairing newly formed elementary body infectivity and delaying the developmental cycle
Xinyang Sun, Wenjing Sang, Shunxin Xu, Leyi Li, Yu Zhao, Xiaofeng Bao · 2026
Read Pyocyanin reversibly inhibits Chlamydia by impairing newly formed elementary body infectivity and delaying the developmental cycle by Xinyang Sun, Wenjing Sang, Shunxin Xu, Leyi Li, Yu Zhao, Xiaofeng Bao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13612364.txt.
Description
Xinyang Sun leads a six-author team dissecting how a bacterial pigment sabotages chlamydia. Pyocyanin, made by Pseudomonas aeruginosa, was known to cripple chlamydia's infectious particles at low doses. The team pinned down where in the pathogen's two-stage life cycle the damage lands. Delayed-treatment experiments and infection assays probed newly formed elementary bodies, the spore-like particles that spread infection between cells.
Complete suppression of progeny took 16 micromolar pyocyanin, while direct attack on incoming particles achieved only about 60 percent. The real action was intracellular: treated bacteria still produced normal numbers of new elementary bodies, but those bodies could barely infect fresh cells. The drug also slowed the growth cycle rather than freezing it, and its grip was reversible. The authors offer pyocyanin as a lab probe for chlamydia biology and a lead compound for a new drug class.
Catalog record
| CREATOR | Xinyang Sun, Wenjing Sang, Shunxin Xu, Leyi Li, Yu Zhao, Xiaofeng Bao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |